These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16936469)

  • 1. If current inhibition: cellular basis and physiology.
    Mangoni ME; Marger L; Nargeot J
    Adv Cardiol; 2006; 43():17-30. PubMed ID: 16936469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart rate reduction by pharmacological If current inhibition.
    Cargnoni A; Ceconi C; Stavroula G; Ferrari R
    Adv Cardiol; 2006; 43():31-44. PubMed ID: 16936470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I; Camm AJ
    Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical perspectives of heart rate slowing for coronary event reduction and heart failure.
    Danchin N; Kadri Z
    Adv Cardiol; 2006; 43():45-53. PubMed ID: 16936471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents.
    DiFrancesco D
    Curr Med Res Opin; 2005 Jul; 21(7):1115-22. PubMed ID: 16004681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future directions: what data do we need?
    Tendera M
    Adv Cardiol; 2006; 43():106-111. PubMed ID: 16936476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D; Camm JA
    Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate lowering by inhibition of the pacemaker current: a new therapeutic perspective in cardiovascular disease.
    Dilaveris P; Giannopoulos G; Synetos A; Gatzoulis K; Stefanadis C
    Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):313-8. PubMed ID: 17073608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the funny current in pacemaker activity.
    DiFrancesco D
    Circ Res; 2010 Feb; 106(3):434-46. PubMed ID: 20167941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine.
    Bucchi A; Baruscotti M; DiFrancesco D
    J Gen Physiol; 2002 Jul; 120(1):1-13. PubMed ID: 12084770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels.
    Bucchi A; Tognati A; Milanesi R; Baruscotti M; DiFrancesco D
    J Physiol; 2006 Apr; 572(Pt 2):335-46. PubMed ID: 16484306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate slowing for myocardial dysfunction/heart failure.
    Mulder P; Thuillez C
    Adv Cardiol; 2006; 43():97-105. PubMed ID: 16936475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.
    Tardif JC
    Drugs Today (Barc); 2008 Mar; 44(3):171-81. PubMed ID: 18536779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiology and pharmacology of the cardiac pacemaker ("funny") current.
    Baruscotti M; Bucchi A; Difrancesco D
    Pharmacol Ther; 2005 Jul; 107(1):59-79. PubMed ID: 15963351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A; Tardif JC
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serious workings of the funny current.
    DiFrancesco D
    Prog Biophys Mol Biol; 2006; 90(1-3):13-25. PubMed ID: 15975637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defying the economists: a decrease in heart rate improves not only cardiac but also endothelial function.
    Triggle CR
    Br J Pharmacol; 2008 Jun; 154(4):727-8. PubMed ID: 18438420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction.
    Su JB
    Curr Pharm Biotechnol; 2014; 14(14):1213-9. PubMed ID: 24831809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effect of 'pure' heart rate slowing with a prototype If current inhibitor: placebo-controlled experience with ivabradine.
    Borer JS
    Adv Cardiol; 2006; 43():54-64. PubMed ID: 16936472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells.
    Bois P; Bescond J; Renaudon B; Lenfant J
    Br J Pharmacol; 1996 Jun; 118(4):1051-7. PubMed ID: 8799581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.